Who invested in Outlook Therapeutics

2 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Raised 7 months ago

Funding summaryUpdated 26 Oct 2026

$23Mraised across 2 rounds since 2026, from 2 sources

$18MDebt$5.0MRound

Latest round: Round, $5.0MApr 2026
Biggest round: $18MDebt · Mar 2026
Investors: 1

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2027

$18MDebt$5.0MRound

First round: Debt, $18M
Biggest round: $18M
Between rounds: 1 month

The rounds

Apr 2026
Round$5.0M1 returning
- Perceptive Advisors
Source recorded
Mar 2026
Debt$18M1 new
- Perceptive Advisors
Source recorded

Founders and team

From Outlook Therapeutics's own website and the SEC filings it signed: 7 on the team.

Bob JahrChief Executive Officer
Jennifer CoutureChief Legal Officer
Kevin LundquistChief Financial Officer
C. Russell TrenaryExecutive Officer, Directori
Faisal G. SukhtianBoard of Directors
Jeff Russell EvansonExecutive Officeri
Lawrence A. KenyonExecutive Officer, Directori

On the board, as filediAndong G. HuangGerd G. AuffarthJulia A. HallerJulian G. GangolliKurt J. HilzingerRandy H. ThurmanYezan H. Haddadin

Everyone who backed them

Perceptive AdvisorsAsset manager2rounds

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Outlook Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.